首页> 外文期刊>Expert opinion on biological therapy >Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario
【24h】

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario

机译:用于治疗非血液肿瘤的单克隆抗体:不断扩大的应用场景的更新

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The identification of cell membrane-bound molecules with a relevant role in cancer cell survival prompted the development of moAbs to block the related pathways. In the last few years, the number of approved moAbs for cancer treatment has constantly increased. Many of these drugs significantly improved the survival outcomes in patients with solid tumours.
机译:简介:对在癌细胞存活中具有重要作用的细胞膜结合分子的鉴定促使moAb的发展,从而阻断了相关途径。在过去的几年中,批准用于癌症治疗的单克隆抗体的数量一直在增加。其中许多药物显着改善了实体瘤患者的生存结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号